HP-TAT Macular Degeneration (NanoPharmaceuticals)

N/A

Report date: 2024/09/02 11:48:23
NME

Base Information

Drug NameHP-TAT Macular Degeneration (NanoPharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanoPharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesNanoPharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A